Imran Khan’s government is poised to inflict damage upon Pakistan’s education system in a manner never seen before. Its so-called Single National Curriculum (SNC) hides systemic changes going far deeper than the ones conceived and executed by the extremist regime of Gen Zia-ul-Haq, writes Pervez Hoodbhoy.
The Drug Controller General of India sent a letter to Mumbai-based pharmaceutical giant Glenmark, accusing the company of selling its newly-approved Covid-19 drug, favipiravir, at an “unreasonable price” through “false claims”, reports Himani Chandna.
Stranded in Germany due to the coronavirus crisis, Monty Majeed writes how she had to sue the Narendra Modi government and Air India to get a seat on a Vande Bharat flight back home to Kerala. She called the government’s NRI “rescue” mission as one of the most stressful times of her life, one that was emotionally and financially draining.
At a time when Russia and China are closer together than they were in earlier decades, and the China-Pakistan relationship is getting stronger, it is natural that New Delhi wonders about the depth of its partnership with US. For all of the Trump administration’s eager support to India, this is a time when America is more or less retracting from its previous role as the global policeman, writes Aparna Pande.
China expert M. Taylor Fravel says border tension between India and China are only going to increase and suggests it’s time for a new agreement between the countries, reports Nayanima Basu.
Human challenge trials are those where participants are exposed to the virus on purpose, which is normally not allowed for ethical reasons. The Jenner Institute, which is working collaboratively on developing the promising vaccine candidate from University of Oxford, is considering human challenge trials to expedite results. Sandhya Ramesh explains what this entails.
Bollywood can be so unfair to the outsider because it is a brutally competitive game with no umpires, adjudicators or whistle-blowers, writes Shekhar Gupta in this week’s ‘National Interest’.